Lower Melatonin Indicates Poor Short-term Prognosis in Patients with Acute Ischemic Stroke
- PMID: 38468527
- DOI: 10.2174/0115672026302380240307091232
Lower Melatonin Indicates Poor Short-term Prognosis in Patients with Acute Ischemic Stroke
Abstract
Aims: We evaluated endogenous melatonin levels in the acute phase of cerebral infarction and explored the impact of possible changes in melatonin levels on the prognosis of patients.
Methods: This study recruited acute ischemic stroke (AIS) patients from the Department of the Second Affiliated Hospital of Soochow University between December 2019 and June 2021, along with healthy control subjects. Salivary melatonin samples were collected from each participant between 7 pm and 10 pm, and fasting plasma was collected the following morning to measure the levels of inflammatory markers. The prognosis was assessed through follow-up three months after discharge. The relationship between melatonin levels and plasma inflammatory markers was assessed, followed by an analysis of the effect of melatonin levels on patient prognosis.
Results: The study enrolled a total of 160 participants, including 120 AIS patients aged 50 years or older (61.7% male) and 40 age-matched controls (55.0% male). The AIS group exhibited lower salivary melatonin levels at 19 (P = 0.002), 20 (P < 0.001), 21 (P < 0.001), and 22 (P < 0.001) o'clock, and the average melatonin level was also lower (P < 0.001). Logistic regression analysis models indicated an association between low melatonin levels and poor prognosis. Salivary melatonin levels demonstrated good predictive ability for the prognosis of AIS patients.
Conclusion: Melatonin levels were lower in AIS patients compared to controls. In addition, lower melatonin levels were associated with a poorer prognosis among AIS patients.
Keywords: Stroke; acute ischemic stroke; inflammation; melatonin; oxidative stress.; prognosis.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
Circadian Rhythm Disturbance in Acute Ischemic Stroke Patients and Its Effect on Prognosis.Cerebrovasc Dis. 2024;53(1):14-27. doi: 10.1159/000528724. Epub 2023 Jul 7. Cerebrovasc Dis. 2024. PMID: 37423205
-
Selected serum cytokines and vitamin D levels as potential prognostic markers of acute ischemic stroke.PLoS One. 2024 Jun 13;19(6):e0299631. doi: 10.1371/journal.pone.0299631. eCollection 2024. PLoS One. 2024. PMID: 38870172 Free PMC article.
-
Risk factors of acute ischemic stroke and the role of angiotensin I in predicting prognosis of patients undergoing endovascular thrombectomy.Front Endocrinol (Lausanne). 2024 Jun 11;15:1388871. doi: 10.3389/fendo.2024.1388871. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38919492 Free PMC article.
-
Increased serum interleukin-34 levels as a novel diagnostic and prognostic biomarker in patients with acute ischemic stroke.J Neuroimmunol. 2021 Sep 15;358:577652. doi: 10.1016/j.jneuroim.2021.577652. Epub 2021 Jun 30. J Neuroimmunol. 2021. PMID: 34217885
-
Inflammatory markers in acute ischemic stroke.Clin Chim Acta. 2025 Mar 1;569:120185. doi: 10.1016/j.cca.2025.120185. Epub 2025 Feb 8. Clin Chim Acta. 2025. PMID: 39929364 Review.
References
-
- Collaborators G.B.D.N.; Global, regional, and national burden of neurological disorders, 1990- 2016: A systematic analysis for the global burden of disease study. Lancet Neurol 2016,18(5),459-480 - DOI
-
- Allen C.L.; Bayraktutan U.; Oxidative stress and its role in the pathogenesis of ischaemic stroke. Int J Stroke 2009,4(6),461-470 - DOI
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical